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The aim of this study was to reveal the biological function of Cj1199 which was
overexpressed in the laboratory induced erythromycin resistant strains. The Cj1199
deletion mutant (8Cj1199) was constructed via insertional inactivation from its parent
strain Campylobacter jejuni NCTC11168. The 8Cj1199 and NCTC11168 were then
subjected to microarray and real-time PCR to find gene pathway of Cj1199. The
antimicrobial susceptibility, antimicrobial resistance development, growth characteristics
and leucine metabolism were examined to confirm the biological function of Cj1199.
Our result showed that a total of 20 genes were down-regulated in 8Cj1199.
These genes were mainly involved in leucine biosynthesis, amino acid transport and
periplasmic/membrane structure. Compared to NCTC11168, 8Cj1199 was difficult to
acquire higher-level erythromycin resistance during the in vitro step-wise selection. The
competition growth and leucine-dependent growth assays demonstrated that 8Cj1199
imposed a growth disadvantage under pressure of erythromycin and in the leucine-free
medium. In conclusion, Cj1199 gene may directly regulate the leucine biosynthesis and
transport and indirectly affect the development of erythromycin resistance in C. jejuni.
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INTRODUCTION
Campylobacter jejuni (C. jejuni), is an important foodborne pathogen whose infection often results
in acute, self-limiting enteritis, but can lead to more serious complications such as Guillain-Barre
Syndrome (Butzler, 2004; Hughes and Cornblath, 2005). Macrolides (mainly erythromycin), which
can bind to the 50S subunit of bacterial ribosome and interfere with protein synthesis by inhibiting
the elongation of peptide chains (Weisblum, 1995), are the valuable antimicrobials of choice to treat
severe Campylobacter infections (Gibreel et al., 2005; EFSA, 2009). Point mutations in domain V of
23S rRNA (Taylor et al., 1997), in the ribosome protein L4/L22 and overexpression of eﬄux pumps
are known as the major causes of resistance in Campylobacter (Lin et al., 2002; Gibreel et al., 2005).
Despite the improved understanding of its general physiology and biochemistry, the molecular
mechanisms involved in Campylobacter fitness and resistance development are largely unknown.
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New approaches, like microarray and RNA-seq, have been
used to determine the transcriptome changes associated with
some gene mutations and the adaptive mechanisms of C. jejuni
to erythromycin treatment (Chaudhuri et al., 2011; Xia et al.,
2013). Our previous study, using a microarray analysis to find the
transcriptional change involved in the development of macrolide
resistance in Campylobacter, showed that a large number of genes
were responsible to the development of macrolide resistance
in Campylobacter, ranging from genes involved in energy
metabolism to macromolecular metabolism to cell processes
(Hao et al., 2013). In these differentially expressed genes, a
gene of unknown function, Cj1199, was overexpressed in the
erythromycin resistant C. jejuni mutants selected from their
parent strains NCTC11168 and 81176. The expression level of
Cj1199 was dose dependent to the level of resistance in the
series erythromycin resistant C. jejuni mutants selected from
NCTC11168. Bioinformatic analyses suggested that Cj1199 may
encode putative iron/ascorbate-dependent oxidoreductase which
may be involved in leucine biosynthesis and consequently affect
the growth of the strains. Many previous studies revealed that
leucine is a key amino acid of erythromycin resistant short
peptides (E-Peptide) in E. coli (Dam et al., 1996; Tenson et al.,
1997; Tripathi et al., 1998; Tenson and Mankin, 2001; Vimberg
et al., 2004). Therefore, Cj1199 may also be associated with
E-Peptide mediated erythromycin resistance. The function of
Cj1199 on the development of macrolide resistance and fitness
has yet to be determined. The objectives of this study were to
decipher functionality and active network of this gene in C. jejuni.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
TheC. jejuniNCTC11168 was kindly provided by Chinese Center
for Disease Control. C. jejuni strains were routinely cultured
on Mueller-Hinton (MH) agar (Oxoid, Basingstoke, UK) or
blood agar plates at 42◦C under microaerophilic conditions.
E. coli DH5α was grown aerobically in Luria-Bertani medium
at 37◦C. The Ham’s F-12 nutrient powder mixture (SH30010,
Thermo Fisher, Waltham, MA, USA) and Ham’s F-12m nutrient
powder mixture (RR13033.01, Thermo Fisher, Waltham, MA,
USA) lacking leucine were used for leucine biosynthesis test.
Construction of Cj1199 Deletion Mutant
A 2.5-Kb fragment containing Cj1199 and its flanking region
was amplified with primers of cj1199F and cj1199R (Table 1) by
PCR and cloned into pGEM-T easy vector (Promega, Madison,
WI, USA) to yield pL1199. A chloramphenicol resistance cassette
(Cmr marker) was amplified from pUOA18 using primers of
ecatF and ecatR. Primers rF and rR were used to inversely amplify
pL1199. The PCR product of the inverse amplification of pL1199
was digested with SmaI and BamHI and ligated with the Cmr
marker to yield plasmid pL1199T. The plasmid pL1199T was
transformed into E. coli DH5α and then introduced to C. jejuni
NCTC11168 by natural transformation (Jeon et al., 2010). The
Cj1199 deletion mutant (8Cj1199) was selected on MH agar
containing chloromycetin (20 µg/ml) and confirmed by PCR and
DNA sequencing.
RNA Extraction
The cells of8Cj1199 or C. jejuni NCTC11168 were grown in MH
agar plate for 24 h at 42◦C under microaerophilic conditions.
For RNA extraction, RNAprotect Bacteria Reagent (Qiagen,
Valencia, CA, USA) was added to the cultures immediately after
the incubation to stabilize mRNA. The total RNA from each
sample was extracted using the RNeasy Protect Mini Kit (Qiagen,
Valencia, CA, USA) following the manufacture’s protocol. RNA
samples were extracted from four independent experiments.
DNA Microarray and Data Analysis
The differential gene expression between 8Cj1199 and C. jejuni
NCTC11168 was identified using DNA microarray which was
supplied by CapitalBio Corporation (Santa Clara, CA, USA).
Briefly, iScript cDNA synthesis kit (BioRad, Hercules, CA, USA)
was used for synthesis of cDNA from an RNA template via
reverse transcription. The cDNA was then labeled with Cy5 or
Cy3 dye. The labeled cDNA probes were co-hybridized onto one
microarray slide (Roche NimbleGen 4 × 72K, Indianapolis, IN,
USA). Hybridized slides were scanned using NimbleGen MS200,
and the fluorescence intensities were collected with NimbleGen
Scan Software. The linear normalization method was used for
data analysis based on expression of the housekeeping genes.
Normalized data was log transformed and loaded into MANOVA
under R environment. Microarray spots with false discovery rate
(FDR)-corrected q-values< 0.01 and fold change≥2 in the T-test
were regarded as differentially expressed genes. The differentially
expressed genes were classified based on the genomic annotation
in NCBI and then subjected to KEGG database for pathway
analysis.
Quantitative Reverse Transcriptase PCR
(qRT-PCR)
The surplus cDNA of 8Cj1199 and C. jejuni NCTC11168 was
subjected to real-time quantitative reverse transcriptase PCR
(qRT-PCR) analysis to confirm the expression of some respective
genes identified by DNA microarray. The primers (Table 1) of
respective genes were designed using Primer 5 software. The qRT-
PCR was performed using SYBR Green Ex TaqTM kit (Takara,
Madison, WI, USA) in IQ5 Multicolor Real-time PCR Detection
System (Bio-Rad) following method described in previous study
(Hao et al., 2010). The qRT-PCR was initiated with a 30 s
denaturation at 95◦C, followed by 38 cycles of amplification with
5 s of denaturation at 95◦C, 30 s of annealing according to the
melting temperatures of amplifications. The melting curve was
performed from 65 to 95◦C (1 s hold per 0.2◦C increase) to check
the specificity of the amplified product.
Determination of Antimicrobial
Resistance (AMR)
Minimum inhibitory concentrations (MICs) of azithromycin
(AZM), erythromycin (ERY), tylosin (TYL), ciprofloxacin (CIP),
nalidixic acid (NAL), olaquindox (OLA), florfenicol (FFC),
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TABLE 1 | Primers used for construction of Cj1199 mutant and for qRT-PCR
Primer name Primer sequence Product size (bp)
Primers used for construction and confirmation of Cj1199 mutant
Cj1199F TAGCGTATTTGATTTGCGTTTT 2536
Cj1199R TATTTGCACCTATTCTTGGGTAA
rF ACCCCGGGAAATGGCTTAGTATACCCCCACT SmaI site 5140
rR ACGGATCCGCTAGTATAACCTCTAAATTGAGG BamHI site
ecatF ACGGATCCAAAGAGTGACCGCCGAGA BamHI 810
ecatR ACCCCGGGCAGTGCGACAAACTGGGA SmaI site
16SF CTGGCTCAGAGTGAACGC 533
16SR CCCTTTACGCCCAGTGATT
hipOF AGAAGCCATCATCGCACCT 148
hipOR TGCTGAAGAGGGTTTGGGT
catF AAAGAGTGACCGCCGAGATA 0/798a
catR CAGTGCGACAAACTGGGATT
Cj1199F TGAACTTACCTATACTTGATT 954/1353b
Cj1199R AAATACTTGCCACATCAG
Primers used for real-time qRT-PCR
cj0560F GCATTTAGGTTTAGGCAAGAAG 159
cj0560R GTCATCGTTTTAATCTCATCGCT
cj0920F CTATTGGTGTATTGGGTGTTGG 184
cj0920R GCTTCAAACTGACCTCTTGGC
cj1241F AGTTACTGGAGTGCCGCTTG 147
cj1241R AGATTGGTTGGGCTAGGATGT
cj1388F CAACTTCCTATCAACCCTGCTTC 221
cj1388R GCACTTCTTGCTGGATAAGGAG
cj1646F CAGGCTGCTTACCAACTCG 275
cj1646R GCATCGCTAATGGCAACG
cj1717cF GCACAGCAAAAGGCACAGG 232
cj1717cR TCATCACTTCTTAAACTCTTCCAAT
q16SF GCTCGTGTCGTGAGATGTTG 199
q16SR GCGGTATTGCGTCTCATTGTAT
aThere should be no amplification product for NCTC11168, while 798 bp product for 8Cj1199; bProduct length of NCTC11168 should be 954 bp, product length of
8Cj1199 should be 1353 bp.
doxycycline (DOX), gentamicin (GEN), and levofloxacin (LEV)
against 8Cj1199 and C. jejuni NCTC11168 were determined
with broth microdilution method following the guidelines of the
Clinical and Laboratory Standards Institute (CLSI, 2006). The
concentrations of the antimicrobial agents tested ranged from
0.01 to 16 µg/mL. The microdilution plates (96 well plates) were
incubated at 42◦C for 24 h and the MIC was determined as the
lowest concentration where visible bacterial growth was inhibited
at the end of the incubation period. C. jejuni ATCC 33560 was
used as a quality control strain.
For the minimal bactericidal concentration (MBC) of drugs
against C. jejuni strains, 100 µL from each well was successively
diluted 1:10 in MH broth. Then 10 µL was spread on MH
agar plates and incubated at 42◦C for 24 h for colony forming
unit (CFU) counting. The MBC was defined as the lowest
drug concentration that resulted in a 99.9% reduction in the
bacterial density. The final result was expressed as mean of five
independent experiments.
The mutant prevention concentration (MPC) of drugs was
determined by agar method (Blondeau et al., 2001). The
inoculum of C. jejuni was concentrated to 1010 CFU/mL.
Bacterial suspensions were inoculated on the agar plates
containing serial dilutions of drugs and cultured for 96 h. The
MPC was the lowest drug concentration on agar plates without
bacterial growth under micro-aerobic conditions.
Erythromycin Tolerance Tested by Flow
Cytometry (FCM)
The concentration of bacteria was adjusted to a 0.5 McFarland
density. Serial twofold dilutions of erythromycin were prepared
with MH broth. The final concentrations of erythromycin ranged
from 0.0625 to 8 µg/mL. A 100 µL aliquot of bacteria was
added to 900 µL MH broth containing different concentrations
of erythromycin and incubated at 42◦C in a micro-aerobic
condition for 3 h. Each dilution was then centrifuged and the
supernatant was discarded. The pellet was washed twice with
sterile PBS and propidium iodide (PI), a membrane-impermeable
DNA-intercalating dye, was used to stain the erythromycin-
treated bacterial cells. One milliliter of buffer and 5 µL of PI
were added to each sample, and then incubated for 30 min at
4◦C. FCM analysis was conducted on CyAn ADPTM FC500 flow
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cytometer with SummitTM software (Beckman Coulter, Miami,
FL, USA). The intensity of fluorescence of 10,000 cells labeled
with PI was analyzed to obtain the mean channel fluorescence
(MCF).
In vitro Selection of Erythromycin
Resistance
8Cj1199 and NCTC11168 were subjected to step-wise selection
in MH agar plate containing erythromycin. In the first
step of selection, cells were plated on MH agar containing
0.25 µg/mL erythromycin. After 3–5 days of incubation under
microaerophilic condition at 42◦C, colonies were selected and
repeatedly incubated with same concentration of erythromycin
up to five times. The mutants obtained from first-step selection
were then subjected to next step selection by exposing the
cells to a twofold increased concentration of erythromycin. The
procedure of selection was repeated up to 10 times to obtain
highly erythromycin-resistant mutants. All in vitro-selected
mutants were subjected to MIC test using the broth microdilution
method as described above.
Single Growth Curve and Pair-Wise
Competition Experiments
Growth curves of 8Cj1199 and C. jejuni NCTC11168 were
measured individually and repeated three times. Briefly, a fresh
C. jejuni culture was diluted 100-fold into 10 mL MH broth and
incubated for up to 36 h. Viable C. jejuni counts were determined
at 4, 12, 24, and 36 h.
Pair-wise competition experiments were used to estimate the
growth rate of 8Cj1199 compared with C. jejuni NCTC11168
in the erythromycin containing (1/2 MIC) or drug-free MH
broth. Briefly, the same densities of the parent and mutant
cultures were prepared before experiments. Equal volumes
(0.1 mL) of adjusted cultures were mixed into 10 mL of
fresh medium with or without erythromycin. After 24 h
incubation, 0.1 mL bacterial culture was then transferred to
another 10 mL fresh medium. The passage was repeated
up to 10 times and the initial and final concentrations of
parent and mutant were determined by standard plate counting
on MH plate with (for the mutant population) or without
10 µg/mL chloromycetin (for the total population), respectively.
The assays were repeated three times with three technical
replicates.
Leucine-Dependent Growth Test
Cultures of 8Cj1199 and C. jejuni NCTC11168 were adjusted
to the same densities at the beginning of the experiments.
Equal volumes (0.1 ml) of adjusted cultures were added into
10 mL Ham’s F-12 and F-12m individually. After 48 h incubation
under microaerophilic conditions at 42◦C, 0.1 mL of bacterial
culture was then transferred to another 10 mL of fresh medium.
The passage was repeated up to five times. Viable C. jejuni
counts were determined by dilution and spatula method on
MH plates (ICC, 1992). The experiment was performed in
triplicate.
RESULTS
Differentially Expressed Genes in
8Cj1199
The 20 genes down-regulated in 8Cj1199 are shown in Table 2.
Five genes (leuA, leuB, leuC, leuD, and trpE) were involved
in amino acid biosynthesis. The leuABCD genes participated
in leucine biosynthesis pathway. Five genes (Cj0919c, Cj0920c,
peb1A, pebC, and ceuC) encoded transporters or binding
proteins. The permease protein (Cj0919c-Cj0920c), substrate-
binding protein (Peb1A), and ATP-binding protein (PebC)
worked cooperatively in an ABC-type amino acid transport
system. The ceuC encoded enterochelin uptake permease which
was also transporters or binding protein. The Cj0246c was
involved in signal transduction. Six genes (Cj0560, Cj1356c,
Cj0423, Cj0424, Cj0425, and Cj0200c) encoded putative integral
membrane or periplasmic proteins. Another three (Cj1025c,
Cj1722c, and Cj1388) were hypothetical genes.
Only Cj1241 gene encoding a putative major facilitator
superfamily (MFS) transport protein was up-regulated in
8Cj1199. Using qRT-PCR to verify the microarray results,
Cj1241 gene was confirmed to be up-regulated, while other four
respective genes (Cj0920c, Cj1388, Cj0560, and Cj1717c) were
confirmed to be down-regulated (Figure 1).
Antimicrobial Susceptibility of 8Cj1199
The antimicrobial susceptibility of the parent and mutant strains
are presented in Table 3. There was no significant difference
between the MIC of 11 antimicrobials in the 8Cj1199 and its
parent strain NCTC11168. Both of the strains exhibited very
low MIC (MIC ≤ 0.5 µg/mL) to the 14, 15, and 16-membered
ring macrolides (erythromycin, azithromycin, and tylosin). The
MBC and MPC of five antimicrobials in 8Cj1199 were similar
(erythromycin, azithromycin, tylosin, olaquindox, and cydox)
with that in NCTC11168 (Table 3).
Erythromycin Tolerance of 8Cj1199
The erythromycin tolerance of 8Cj1199 to increased
concentration of erythromycin was detected by flow cytometer
analysis. As shown in Figure 2, the mean value of the
fluorescence intensity was increased following the increase of
erythromycin concentration. However, when the concentration
of erythromycin reached to their MIC (0.125 µg/mL), the mean
PI intensity of C. jejuni NCTC11168 was significantly decreased,
while the mean PI intensity of 8Cj1199 kept at its highest level.
Under the treatment of different concentrations of erythromycin,
the mean PI intensity of 8Cj1199 was higher than that of parent
strain, which indicated that 8Cj1199 had higher mortality and
lower tolerance to erythromycin.
Development of Erythromycin
Resistance In vitro
There was no significant difference between 8Cj1199 and
NCTC11168 in the first and second steps of selections.
When transferred to third step selection by 1 µg/mL
erythromycin, 8Cj1199 descendants exhibited less growth
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TABLE 2 | Differentially expressed genes in the mutant of 8Cj1199 comparing to its parent strain NCTC 11168.
Function class Gene name Gene function Fold change
Signal tranduction Cj0246c putative MCP-domain signal transduction protein 0.3624
Transporters/ binding proteins Cj0919c putative ABC-type amino-acid transporter permease 0.4997
Cj0922c/pebC amino-acid ABC transporter ATP-binding protein 0.461
Cj0921c/peb1A bifunctional adhesin/ABC transporter aspartate/glutamate-binding protein 0.4597
Cj0920c putative ABC-type amino-acid transporter permease 0.3920
Cj1353/ceuC enterochelin uptake permease 0.4557
Cj1241 putative MFS transport protein/Arabinose efflux permease 2.3237
Amino acid biosynthesis Cj1716c/leuD isopropylmalate isomerase small subunin 0.3996
Cj1717c/leuC isopropylmalate isomerase large subunin 0.378
Cj1718c/leuB 3-isopropylmalate dehydrogenase 0.348
Cj1719c/leuA 2-isopropylmalate synthase 0.3167
Cj0345/trpE putative anthranilate synthase componentI 0.4076
Cell envelop Cj0560 putative MATE family transport protein 0.3564
Cj1356c putative integral membrane protein 0.4983
Cj0423 putative integral membrane protein 0.4534
Cj0425 putative periplasmic protein 0.4918
Cj0424 putative acidic periplasmic protein 0.4483
Cj0200c putative periplasmic protein 0.4689
Hypothetical proteins and unknown function proteins Cj1025c hypothetical protein 0.4974
Cj1722c hypothetical protein 0.4727
Cj1388 putative endoribonuclease L-PSP 0.3849
FIGURE 1 | Differential expression of target genes in 8Cj1199 and NCTC11168 determined by real-time qRT-PCR and microarray. The genes were
randomly selected. RNA used for real-time qRT-PCR and microarray were prepared in the same time.
than NCTC11168 descendants. When transferred to fourth step
of selection, 8Cj1199 descendants could not grow on MH agar
containing 2 µg/mL erythromycin, while C. jejuni NCTC11168
descendants grew well and successfully promoted to fifth step
of selection by 4 µg/mL erythromycin. The erythromycin
MIC of mutants selected from NCTC11168 was equal to
or higher than 128 µg/mL, which was significantly higher
than erythromycin MIC (4 µg/mL) of mutants selected from
8Cj1199.
Growth Disadvantage of 8Cj1199
The 8Cj1199 and NCTC11168 were separately cultured in
macrolide-free MH broth. No significant difference in growth
rates was observed between the two strains in single cultures
(Figure 3A).
When 8Cj1199 and NCTC11168 were mixed in pairs into
drug-free MH broth, population of 8Cj1199 was decreased after
the fifth passage and reduced by twofolds of magnitude after the
10th passage (Figure 3B).
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TABLE 3 | Minimum inhibitory concentration (MIC)/minimal bactericidal concentration (MBC)/mutant prevention concentration (MPC) of wild-type and
mutant strains to different types of drugs.
Drug Strains
Mutant NCTC 11168
MIC (µg/mL) MBC (µg/mL) MPC (µg/mL) MIC (µg/mL) MBC (µg/mL) MPC (µg/mL)
ERY 0.125 0.25 0.25 0.125 0.125 0.25
TYL 0.5 1 1 0.5 1 1
AZI 0.015 / 0.031 0.015 / 0.031
OLA 0.25 0.5 0.5 0.25 0.5 0.5
CYA 0.25 0.5 0.5 0.25 0.5 0.5
FFC 0.5 / / 0.5 / /
GEN 0.125 / / 0.125 / /
NAL 8 / / 8 / /
CIP 0.062 / / 0.062 / /
LEV 0.062 / / 0.062 / /
DOX 0.125 / / 0.125 / /
ERY, erythromycin; TYL, tylosin; AZM, azithromycin; FFC, florfenicol; GEN, gentamicin; NAL, nalidixic acid; CIP, ciprofloxacin; LEV, levofloxacin; DOX, doxycycline; OLA,
olaquindox; CYA, cydox. The “/” means not detected.
FIGURE 2 | Mean values of PI stain of 8Cj1199 and NCTC11168 cultured with different concentrations of erythromycin. The asterisk (∗) and (∗∗)
represent statistical significant difference with P ≤ 0.05 and P ≤ 0.01 comparing with C. jejuni NCTC11168, respectively.
In the mixture culture containing 1/2 MIC erythromycin,
population of 8Cj1199 was reduced during passages. The
8Cj1199 was outcompeted by NCTC11168 in the drug-
containing culture after the fourth passage (Figure 3C).
Leucine-Dependent Growth
There is no significant difference of the growth between 8Cj1199
and NCTC11168 in the medium F-12. Both of them grew well
after five passages in the medium F-12 (Figure 4). However, the
number of 8Cj1199 was remarkably decreased during the five
times of passage in the medium F-12m. After the fifth passages
in the medium F-12m, the number of 8Cj1199 mutant had
been reduced by two orders of magnitude comparing with its
parent strain NCTC11168 which kept at the level of 105 CFU/mL.
Conclusively, in absence of leucine, the growth of 8Cj1199 was
much slower than NCTC11168.
DISCUSSION
To our knowledge, this is the first study of the function of
Cj1199 on the development of macrolide resistance and biological
characteristics ofC. jejuni. Previously, Cj1199, a gene of unknown
function, was up-regulated in the macrolide resistant C. jejuni
mutants selected by step-wise increased erythromycin in vitro
from their parent strains NCTC11168 and 81176 (Hao et al.,
2013). Bioinformatic analyses suggested that Cj1199 may encode
putative iron/ascorbate-dependent oxidoreductase. This gene
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FIGURE 3 | Single growth curve and competitive growth of 8Cj1199 and NCTC11168 in the culture with or without erythromycin. (A) Bacterial culture
grown in MH for 36 h. Viable colonies were determined at 5, 15, 25, and 35 h. (B,C) Pair-wise competition of C. jejuni NCTC11168 and mutant was determined
during 5–10 passages in the mixed culture. The Initial and final concentrations were determined by standard plate count on MH or MH with chloromycetin. The
asterisk (∗) and (∗∗) represent statistical significant difference with P ≤ 0.05 and P ≤ 0.01 comparing with C. jejuni NCTC11168, respectively.
was located in the downstream of luxS and over-expressed in
the luxS null mutation (He et al., 2008). Therefore, the function
of Cj1199 attracted our attention. The gene knockout method,
microarray assay, antimicrobial susceptibility test, FCM, and
growth determination were used to find out the function and
molecular mechanism of Cj1199.
From the microarray data, four genes (Cj0921c-Cj0919c-
Cj0920c-Cj0922c) involved in amino acid transporters were
obviously down-regulated in 8Cj1199. The Cj0921c gene was
known to encode a bifunctional adhesin/ABC transporter
aspartate/glutamate-binding protein (Peb1A; Pei and Blaser,
1993; Leon-Kempis Mdel et al., 2006). The Peb1A had higher
affinity to both aspartate and glutamate, thus it could bind
aspartate and glutamate as specific substrates to initiate the
nutrient transport systems in gram-negative species (Pei and
Blaser, 1993; Leon-Kempis Mdel et al., 2006). The glutamine
could modulate bacterial metabolism of the arginine family
as well as serine and aspartate families of amino acid and
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FIGURE 4 | The leucine-dependent growth test. The growth curve of NCTC11168 and 8Cj1199 in Ham’s F12 and Ham’s F12m were determined. The asterisk
(∗) and (∗∗) represent statistically significant difference with P ≤ 0.05 and P ≤ 0.01 comparing with C. jejuni NCTC11168, respectively.
could reduce catabolism of most nutritionally essential amino
acids including lysine, leucine, valine and serine, thus it may
initiate signaling pathways related to amino acid metabolism
in the intestinal bacteria (Dai et al., 2012, 2013). As shown in
previous studies, peb1A was essential for the growth, invasion
and intestinal colonization of Campylobacter species (Kervella
et al., 1993; Pei et al., 1998; Leon-Kempis Mdel et al., 2006;
Muller et al., 2007). Under a microaerobic environment, peb1A
deficient mutants cannot grow on dicarboxylic amino acids
which were the major nitrogen source (Leon-Kempis Mdel
et al., 2006). In C. jejuni, the mutation in peb1A locus could
reduce the interactions with epithelial cells and intestinal
colonization of mice (Pei et al., 1998). There was no report about
the characteristic of the other three genes (Cj0919c-Cj0920c-
Cj0922c). The string 9.0 and KEGG analysis revealed that these
four genes have close interaction with each other and they may
work synergistically in the amino acid transport system. The gene
cluster (Cj0921c-Cj0919c-Cj0920c-Cj0922c) may be essential for
the uptake of nitrogen source which was indispensable for the
growth and fitness of Campylobacter species. However, it is still
unknown that how Cj1199 effects the expression of Cj0921c-
Cj0919c-Cj0920c-Cj0922c gene cluster.
The leuABCD gene cluster was involved in leucine
biosynthesis (Labigne et al., 1992). The leuA encoded alpha-
isopropylmalate synthase (alpha-IPMS) which was key enzyme
to catalyze the first committed step in the leucine biosynthetic
pathway (Yindeeyoungyeon et al., 2009). The leuB gene encoded
3-isopropylmalate dehydrogenase, while leuC and leuD genes
encoded the large and small subunits of isopropylmalate
isomerase, respectively (Tamakoshi et al., 1998). The leuB gene
was reported to be essential for the survival in starvation, colony
formation and growth in the Enterobacteriaceae (Matsumoto
et al., 2011). In the sequences of leuC and leuD, cysteine residues
for iron-sulfur binding and other amino acid residues involved
in isomerase activity were highly conserved (Tamakoshi et al.,
1998). The transcriptional derepresssion of a leuC-defective
allele leaded to accumulation of Leu (+) mutations (Martin
et al., 2011). Recent studies revealed that the leuABCD gene
cluster also participated in the formation of norvaline and
norleucine from 2-ketobutyrate and potentially contributed to
non-polymeric carbon-chain elongation, which was essential
in the synthesis of non-native metabolites in microorganisms
(Sycheva et al., 2007; Shen and Liao, 2011). The coordinated
expression of the functionally related leuABCD gene clusters
may be mediated by LeuO and governed by transcription-driven
DNA supercoiling (Chen et al., 2003; Wu and Fang, 2003).
Our study indicated that the inactivation of Cj1199 impacted
the coordinated expression of leuABCD genes. However,
the molecular mechanism involved in the regulation is still
unknown. The leucine biosynthesis was versatile for many
biogenic processes in prokaryotic and eukaryotic organisms.
In the yeast and human cells, leucine biosynthesis regulated
cytoplasmic iron-sulfur enzyme biogenesis in an atm1p (ABC
transporter)-independent manner (Bedekovics et al., 2011). In
many enteric bacteria and fungi, leucine, or a precursor of leucine
can be used to regulate peripheral nitrogen metabolism with
other cellular processes and can be selected directly or indirectly
as a signal molecule in a wider metabolic context by very different
mechanisms (Kohlhaw, 2003). Thus, leucine biosynthesis acts as
a back door for effecting metabolism in cells (Kohlhaw, 2003).
Little is known about the gene cluster encoding putative
membrane proteins (Cj0423-Cj0424-Cj0425). However, the
Cj0425 gene was considered to be an important contributor to
the oxygen requirement and tolerance of C. jejuni (Kaakoush
et al., 2007). The function of the other three genes involved in
cell envelop (Cj0560, Cj1356c, and Cj0200c) is still unknown, but
they may affect the fitness of 8Cj1199.
The down-regulation of the genes involved in amino acid
transport and biosynthesis, and the genes encoding cell envelop
may result in the disadvantage of nutrient utilization and growth
in 8Cj1199. This hypothesis was confirmed by a series of
competitive growth tests in the present study. Although there
was no significant change in the short-term and single growth
tests, the remarkable disadvantage of 8Cj1199 was observed
in the long-term and competitive growth tests. Therefore, the
Cj1199 gene was essential for the fitness (growth) of C. jejuni by
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controlling the expression of the several genes involved in amino
acid transport and leucine biosynthesis pathway.
According to the previous literature, a mechanism of
macrolide resistance based on the expression of a specific
short peptide in the cell was discovered several years ago
(Tenson and Mankin, 1995; Tenson et al., 1996). The Shine-
Delgarno region of the mini-gene encoding the short peptide
was located in the 23S rRNA secondary structure (Tenson and
Mankin, 2001). The peptide rendering C. jejuni resistance to
erythromycin was one of the C-peptides. It bound erythromycin
and removed the drug from its binding site of the ribosome
and then sequestered it in an inactive complex (Tripathi et al.,
1998). C-peptides showed a very strong bias in amino acid
composition with a prevalence of the hydrophobic amino acid
residues Leu, Ile, Val, Ala, Phe, and Trp. The most conserved
position was the third, which was most commonly occupied
by leucine. Therefore, it was presumable that the obstruction
of leucine biosynthesis may lead to the failure of short peptide
synthesis in the environment containing erythromycin. However,
the role of Cj1199 on the formation of C-peptides was not
verified. No difference of the MIC between 8Cj1199 and
NCTC11168 was observed in our study. Considering the limited
sensitivity of MIC determination by broth microdilution method,
the erythromycin susceptibility was detected by FCM, the
result indicated that the tolerance of 8Cj1199 to erythromycin
was decreased under the treatment by a series concentration
of erythromycin. Additionally, 8Cj1199 showed remarkable
disadvantage on the development of erythromycin resistance
in vitro step-wise selection. Therefore, Cj1199 may not directly
impact on the erythromycin resistance, but it can contribute
to the initial survival rate of the bacteria during erythromycin
treatment and may increase the chances of acquiring resistance.
CONCLUSION
8Cj1199 exhibited a weak competition of growth in a variety
of competitive environments, especially in the medium with
erythromycin. 8Cj1199 possessed lower risk for development
of erythromycin resistance. Based on functions of differentially
expressed genes, Cj1199 has an impact on the biosynthesis of
leucine and utilization of amino acid in gut, and thus may play
an important role in the synthesis of short peptide and in the
provision of energy and carbon. The genotype and phenotype
change of 8Cj1199 indicates that Cj1199 may contribute to
the initial survival and colonization of the C. jejuni under
the antibiotic treatment. Cj1199 may impact the resistance
acquirement or resistance development in a long term but not in
a short term of growth. The role of Cj1199 on the development of
erythromycin resistance is indirectly dependent on the regulation
of the expression of genes involved in amino acid biosynthesis
and utilization. This study widened our understanding on
the molecular mechanism of resistance and provides scientific
reference for drug research and application.
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